Login / Signup

Mid-Term Results of an Italian Multicentric Experience with the Roadsaver TM Dual-Layer Carotid Stent System.

Olga SilvestriGiulio AccarinoDavide TurchinoFrancesco SquizzatoMichele PiazzaMartina BastianonSara Di GregorioGiovanni PratesiMichele AntonelloDavide CostaRaffaele SerraUmberto Marcello Bracale
Published in: Healthcare (Basel, Switzerland) (2024)
As most recent, high-quality studies show, the CAS procedure with second-generation devices such as the Roadsaver stent is safe and effective in preventing carotid-related cerebrovascular events in both symptomatic and asymptomatic patients. The intraoperative and postoperative cerebrovascular complication rate in high volume centers is very low, ensuring confidence in its employment for the CAS procedure along with a CPD as a valid alternative to CEA.
Keyphrases
  • crispr cas
  • end stage renal disease
  • genome editing
  • newly diagnosed
  • ejection fraction
  • patients undergoing
  • chronic kidney disease
  • minimally invasive
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes